SCHEMBL20223056

SCHEMBL20223056

CC(=O)/C=C/c1cc(Cl)nc(N)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 3/20 0.41
▸ LMNA P02545 2/20 0.41
▸ CYP2C19 P33261 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ MAPT P10636 2/20 0.41
▸ HTT P42858 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ HSP90AB1 P08238 5/20 0.36
▸ HSP90AA1 P07900 4/20 0.36
▸ MEN1 O00255 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ GLA P06280 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ IAPP P10997 1/20 0.34
▸ PTGS1 P23219 1/20 0.34
▸ GRM4 Q14833 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20212171 0.85 KDM4E (0.39) KDM4ELMNACYP2C19MAPTKMT2A
SCHEMBL20223478 0.79 TTR (0.43) KDM4ESMN1; SMN2MAPTKMT2AALDH1A1
SCHEMBL30036780 0.79 TTR (0.43) KDM4ESMN1; SMN2MAPTKMT2AALDH1A1
SCHEMBL27403418 0.72 HSP90AB1 (0.43) KDM4ELMNACYP2C19SMN1; SMN2MAPT
SCHEMBL7420123 0.70 HSP90AB1 (0.42) KDM4ELMNACYP2C19SMN1; SMN2MAPT
SCHEMBL10619597 0.69 CYP2D6 (0.40) KDM4ELMNACYP2C19SMN1; SMN2MAPT
SCHEMBL3187486 0.68 GRM4 (0.66) KDM4EMAPTKMT2AHSP90AB1HSP90AA1
SCHEMBL3187493 0.68 GRM4 (0.66) KDM4EMAPTKMT2AHSP90AB1HSP90AA1
SCHEMBL140640 0.66 — —
SCHEMBL18031328 0.66 APP (0.37) KDM4ELMNACYP2C19SMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180155298-A1 PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS Apros Therapeutics, Inc. 2018-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180155298-A1 PYRIMIDINE COMPOUNDS CONTAINING ACIDIC GROUPS MAVS, TLR7, STING1 KDM4E 3029/4885LMNA 4274/4885CYP2C19 4563/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback